The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
It has been shown recently that metabolic syndrome is associated with gut dysbiosis. The gut microbiota may be the main target for prevention or treatment of metabolic syndrome. We investigated the effects of synbiotic supplementation on metabolic syndrome. In this triple-blinded clinical trial, 46 Iranian patients with metabolic syndrome, from both sexes, aged 25–70 years, who fulfilled inclusion criteria were randomly categorized to receive either the synbiotic or a placebo capsule, twice a day for three months, plus a weight-loss diet using stratified random sampling based on body mass index (BMI). Each synbiotic capsule consisted of seven strains probiotic bacteria (2× 108) plus fructooligosaccharide as a prebiotic. Anthropometric measurements and biochemical tests were assessed at baseline and at the end of week 12 for fasting blood sugar (FBS), insulin, lipid profile, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), peptide YY (PYY), and glucagon-like peptide-1 (GLP-1). The mean changes of weight, BMI, FBS, insulin, homeostatic model assessment for insulin resistance (HOMA-IR), and GLP-1 between the two groups was statistically significant (p < .001). Furthermore, peptide YY (PYY) increased significantly in the synbiotic group (p ≤ .05). The trend of weight loss in the synbiotic group was significant until the end of the study (p < .001) while it stopped at week 6 in the placebo group. Synbiotic treatment may improve the status of BMI, FBS, insulin resistance, HOMA-IR, GLP-1, and PYY in patients with metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dietary interventions, particularly those targeting the relationship between macronutrients and microbiome, can affect postprandial GLP-1 secretion but cannot replace pharmacological treatments [114].”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [114]
In the citing paper
“Dietary interventions, particularly those targeting the relationship between macronutrients and microbiome, can affect postprandial GLP-1 secretion but cannot replace pharmacological treatments [114].”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [114]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“On the other hand, some authors have suggested that SCFAs produced by probiotic bacteria fermentation can cause a decrease in the systemic levels of blood lipids (Qin et al., 2012).”
BackgroundAFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,149
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · cited 2×
“…and BMI may be mediated by cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), which are expressed in adipose tissue (Visser et al., 1999) and are the main regulators of CRP production in the liver (Hotamisligil, Arner, Caro, Atkinson, & Spiegelman, 1995; Purohit et…”
BackgroundButyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204 · cited 2×
“Gao et al. (2009) have shown that adding butyrate to the high-fat diet increased insulin sensitivity and reduced obesity in C57BL/6 mice (Puddu et al., 2014).”
BackgroundThe Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146 · cited 1×
“On the other hand, Nestel, Connor, & Reardon (1984) has proposed that inhibition of proinflammatory cytokines would prevent insulin resistance (Baumann & Gauldie, 1994; Papanicolaou et al., 1998).”
BackgroundGut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860 · cited 1×
“It seems that it is a mutual relation, such that low-grade inflammation is related to the changes in composition of intestinal gut microbiota (Cani, Delzenne, Amar, & Burcelin, 2008; Tilg & Kaser, 2011).”
BackgroundWang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., van-Hylckama Vlieg, J. E. T., Strissel, K., Zhao, L., Obin, M., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2014.99 · Cited by 836 · cited 2×
“sumption as a new strategy to treat obesity, disorders of lipid profile, insulin resistance, and inflammation (Wang et al., 2015; De Preter, Hamer, Windey, & Verbeke, 2011; Teixeira, Collado, Ferreira, Bressan, & Peluzio Mdo, 2012; Lesniewska et al., 2006), but data in humans are currently scarce and controversial.”
Background
Research works printed but not linked: 12
- Drisko J, 2003, Altern Med Rev, 8, 143
- Ejtahed H, 2011, Int J Endocrinol Metab, 13, 1
- Friedewald WT, 1972, Clin Chem Biol Interact, 18, 499
- Kelishadi R, 2001, Shahrekord Univ Med Sci, 3, 55
- Lee S, 2013, Clin Nutr, 13, 329
- Mazloom Z, 2013, Iran J Med Sci, 38, 38
- Nordgaard I, 1995, Nutrition, 11, 129
- Pataky Z, 2009, Rev Med Suisse, 5, 662
- Pereira D, 2002, Biochem Mol Biol, 37, 259
- Purohit A, 1995, J Clin Endocrinol Metab, 80, 3052
- Rabiei S, 2015, Med J Islam Repub Iran, 26, 213
- Zarrati M, 2014, J Am Coll Nutr, 31, 1
Cited by
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
Kazemi, A., Soltani, S., Ghorabi, S., Keshtkar, A., Daneshzad, E., Nasri, F., & Mazloomi, S. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.004 · Cited by 131
da Silva, T. F., Casarotti, S. N., de Oliveira, G. L. V., & Penna, A. L. B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1733483 · Cited by 127
Hadi, A., Alizadeh, K., Hajianfar, H., Mohammadi, H., & Miraghajani, M. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1545218 · Cited by 80
The Microbiota–Gut–Brain Axis in Metabolic Syndrome and Sleep Disorders: A Systematic Review
dos Santos, A., & Galié, S. (2024) · Nutrients · doi:10.3390/nu16030390 · Cited by 92
“A great role seems to be ascribed to the symbiotic treatments, with a beneficial effect on insulin concentrations and resistance, glucose levels, and BMI in MetS subjects [82].”
Background
Metadata
- Authors
- Rabiei, S., Hedayati, M., Rashidkhani, B., Saadat, N., & Shakerhossini, R.
- Affiliations
- National Nutrition and Food Technology Research Institute (IR)
- Research Institute for Endocrine Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Corresponding author
- Rabiei, Samira
- Venue
- Journal of Dietary Supplements
- Publisher
- Informa UK Limited
- Published
- 2018-04-19
- Volume
- 16
- Issue
- 3
- Pages
- 294-306
- ISSN
- 1939-0211 (ISSN-L)
- 1939-022X
- OpenAlex
- W2802638297
- Cited by
- 76
- References
- 52
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 7 · 2022: 11 · 2021: 15 · 2020: 8 · 2019: 3 · 2018: 1
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Dietary Supplements (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Nutrition and Food Technology Research Institute
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- synbiotic supplementation, metabolic syndrome, probiotics, prebiotics, fructooligosaccharides, gut microbiota, gut dysbiosis, body mass index, weight loss, insulin resistance, HOMA-IR, fasting blood glucose, insulin, C-reactive protein, interleukin-6, peptide YY, glucagon-like peptide-1, appetite, weight loss diet
- MeSH terms
- Adult, Aged, Appetite, Blood Glucose, C-Reactive Protein, Fasting, Female, Humans, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Research Design, Biomarkers, Body Mass Index, Treatment Outcome, Inflammation Mediators, Peptide YY, Metabolic Syndrome, Synbiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial. https://app.cochat.ai/papers/10.1080/19390211.2018.1455788
- The paper
- Rabiei, S., Hedayati, M., Rashidkhani, B., Saadat, N., & Shakerhossini, R. (2019). The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial. Journal of Dietary Supplements. https://doi.org/10.1080/19390211.2018.1455788
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.